NCT06212440View on ClinicalTrials.gov

Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

May 4, 2021

Primary Completion Date

August 14, 2024

Study Completion Date

October 2, 2024

Conditions
Sentinel Lymph Node BiopsyNeoadjuvant TherapyBreast Neoplasm
Interventions
DIAGNOSTIC_TEST

Radioactive Isotope (RI) Mapping

Administered via peritumoral or subareolar injection for sentinel lymph node detection.

DIAGNOSTIC_TEST

Indocyanine Green Fluorescence (ICG-F) Mapping

Administered via peritumoral or subareolar injection, detected using near-infrared fluorescence imaging.

DIAGNOSTIC_TEST

Vital Dye Mapping

Administered via peritumoral or subareolar injection for intraoperative visualization of lymphatic drainage pathways.

Trial Locations (2)

82

National cancer center, Goyang-si

410-769

National Cancer Center, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV